✦ LIBER ✦

A phase II trial of EMD72000 (matuzumab), a humanized anti-EGFR monoclonal antibody, in patients with platinum-resistant ovarian and primary peritoneal malignancies

✍ Scribed by M.V. Seiden; H.A. Burris; U. Matulonis; J.B. Hall; D.K. Armstrong; J. Speyer; J.D.A. Weber; F. Muggia

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of a phase I trial of the humani

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Phase II trial of lapatinib and topoteca

✍ S. John Weroha; Ann L. Oberg; Katie L. Allen Ziegler; Shaker R. Dakhilm; Kendrit 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 240 KB

Evaluation of Monoclonal Humanized Anti-

✍ Bookman, M. A. 📂 Article 📅 2003 🏛 American Society of Clinical Oncology 🌐 English ⚖ 108 KB

Phase II trial of imatinib mesylate in p

✍ Robert L. Coleman; Russell R. Broaddus; Diane C. Bodurka; Judith K. Wolf; Thomas 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 110 KB

A phase II trial of weekly docetaxel in

✍ Anna Berkenblit; Michael V. Seiden; Ursula A. Matulonis; Richard T. Penson; Caro 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 169 KB

A phase II, single-arm study of the anti

✍ Katherine M. Bell-McGuinn; Carolyn M. Matthews; Steffan N. Ho; Minal Barve; Lucy 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 586 KB